Chi-Ching Mak

Chi-Ching Mak is a notable inventor based in San Diego, CA, who has made significant contributions to the field of neuropharmacology. He holds 2 patents that focus on innovative chemical compounds with potential therapeutic applications.

Latest Patents

His latest patents include "Substituted naphthyridine and quinoline compounds as MAO inhibitors." This invention provides a chemical entity of Formula (I) wherein R, R, R, Y, and n have various values described in the patent. The compounds are designed for use in a wide range of methods, including metabolic and reaction kinetic studies, detection and imaging techniques, and radioactive treatments. They also have therapeutic applications, such as inhibiting MAO and MAO-B selectively, enhancing neuronal plasticity, treating neurological disorders, providing neuroprotection, and addressing cognitive impairments associated with CNS disorders. Furthermore, these compounds aim to enhance the efficiency of cognitive and motor training, support neurorecovery and neurorehabilitation, and treat peripheral disorders, including obesity, diabetes, and cardiometabolic disorders.

Career Highlights

Chi-Ching Mak has worked with several prominent companies in the neuroscience sector, including Dart Neuroscience and Cayman Ltd. His work has been instrumental in advancing the understanding and treatment of neurological conditions.

Collaborations

Throughout his career, Chi-Ching has collaborated with notable colleagues, including Jillian Basinger and Graeme Freestone, contributing to a dynamic research environment.

Conclusion

Chi-Ching Mak's innovative work in developing MAO inhibitors showcases his commitment to advancing neuropharmacology. His contributions have the potential to significantly impact the treatment of various neurological disorders and improve cognitive health.

Profile summary based on public USPTO records.